Why have total cholesterol levels declined in most developed countries?

被引:38
作者
Capewell, Simon [1 ]
Ford, Earl S. [2 ]
机构
[1] Univ Liverpool, Liverpool L69 3BX, Merseyside, England
[2] Ctr Dis Control & Prevent, Atlanta, GA USA
来源
BMC PUBLIC HEALTH | 2011年 / 11卷
关键词
CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; MORTALITY-RATES; RISK; DECREASE; TRENDS; SWEDEN; ADULTS; LIPIDS;
D O I
10.1186/1471-2458-11-641
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Our paper addresses three major public health issues: cholesterol, statins and policies to prevent cardiovascular disease. Discussion: Total cholesterol levels in whole populations have fallen substantially in the USA, UK and most other developed countries. This has greatly contributed to decreases in cardiovascular disease deaths. The evidence identifying diet as the major contributor to these historical falls in cholesterol is powerful and consistent. Large falls occurred before statins were introduced. Additional substantial falls occurred before statins were widely used. Now, up to 14% adults in Western populations currently receive statins for primary prevention. Furthermore, because diet is now only slowly improving, the statin contribution currently appears proportionately larger. Summary: In conclusion, diet change explains most of the historical falls in cholesterol. Until very recently, the contribution from statins has been surprisingly modest. Furthermore, many middle income countries may have neither the resources nor the infrastructure for mass statin therapy. Further substantial falls in cholesterol are therefore unlikely to be obtained simply by increased use of statins or dietary advice to individuals if unsupported by the wider environment. This further emphasises the need for more effective structural policies. Regulatory and fiscal interventions could easily eradicate industrial transfats, halve the intake of dietary saturated fat, and subsidise healthier fats.
引用
收藏
页数:5
相关论文
共 22 条
[1]   Analysing the Large Decline in Coronary Heart Disease Mortality in the Icelandic Population Aged 25-74 between the Years 1981 and 2006 [J].
Aspelund, Thor ;
Gudnason, Vilmundur ;
Magnusdottir, Bergrun Tinna ;
Andersen, Karl ;
Sigurdsson, Gunnar ;
Thorsson, Bolli ;
Steingrimsdottir, Laufey ;
Critchley, Julia ;
Bennett, Kathleen ;
O'Flaherty, Martin ;
Capewell, Simon .
PLOS ONE, 2010, 5 (11)
[2]   Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [J].
Baigent, C ;
Keech, A ;
Kearney, PM ;
Blackwell, L ;
Buck, G ;
Pollicino, C ;
Kirby, A ;
Sourjina, T ;
Peto, R ;
Collins, R ;
Simes, J .
LANCET, 2005, 366 (9493) :1267-1278
[3]   Explaining the recent decrease in coronary heart disease mortality rates in Ireland, 1985-2000 [J].
Bennett, K ;
Kabir, Z ;
Unal, B ;
Shelley, E ;
Critchley, J ;
Perry, I ;
Feely, J ;
Capewell, S .
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2006, 60 (04) :322-327
[4]   Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002 [J].
Bjorck, Lena ;
Rosengren, Annika ;
Bennett, Kathleen ;
Lappas, George ;
Capewell, Simon .
EUROPEAN HEART JOURNAL, 2009, 30 (09) :1046-1056
[5]   Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994 [J].
Capewell, S ;
Morrison, CE ;
McMurray, JJ .
HEART, 1999, 81 (04) :380-386
[6]   Explanation for the decline in coronary heart disease mortality rates in Auckland, New Zealand, between 1982 and 1993 [J].
Capewell, S ;
Beaglehole, R ;
Seddon, M ;
McMurray, J .
CIRCULATION, 2000, 102 (13) :1511-1516
[7]   Will Cardiovascular Disease Prevention Widen Health Inequalities? [J].
Capewell, Simon ;
Graham, Hilary .
PLOS MEDICINE, 2010, 7 (08)
[8]   Potential Reductions in United States Coronary Heart Disease Mortality by Treating More Patients [J].
Capewell, Simon ;
O'Flaherty, Martin ;
Ford, Earl S. ;
Critchley, Julia A. .
AMERICAN JOURNAL OF CARDIOLOGY, 2009, 103 (12) :1703-1709
[9]   Trends in serum lipids and lipoproteins of adults, 1960-2002 [J].
Carroll, MD ;
Lacher, DA ;
Sorlie, PD ;
Cleeman, JI ;
Gordon, DJ ;
Wolz, M ;
Grundy, SM ;
Johnson, CL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (14) :1773-1781
[10]  
Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619